Mylan Sues FDA, Seeks Injunction Against Macrobid “Authorized” Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
The lawsuit, filed in Clarksburg, W.Va. federal court, says authorized generic deals “deter competition by discouraging challenges to even the weakest patents.”